combination therapy

Research in Review

Neoadjuvant Endocrine Therapy for Breast Cancer Produces Same Results as Combination Chemotherapy

07/08/2016

JCP Editors

Neoadjuvant endocrine therapy (NET) may be associated with similar response rates as neoadjuvant combination chemotherapy, but with significantly lower toxicity, findings from a study published in JAMA Oncology...

...

07/08/2016

Journal of Clinical Pathways

Research in Review

Immunotherapeutic Agents May Cause Arthritis

06/24/2016

JCP Editors

Cancer treatment with the immune checkpoint inhibitors nivolumab and ipilimumab may cause patients to develop inflammatory arthritis or sicca syndrome, claims a study conducted by a group of researchers at Johns...

Cancer...

06/24/2016

Journal of Clinical Pathways

Research in Review

Second-line Treatment Option Identified for Small Cell Lung Cancer

06/23/2016

JCP Editors

A regimen containing cisplatin, etoposide, and irinotecan may be clinically beneficial as a second-line treatment for certain patients with small cell lung cancer, according to a clinical trial conducted in...

A...

06/23/2016

Journal of Clinical Pathways

Drug Combination Reduces Adverse Events and Need for Dose Reductions

06/02/2016

JCP Editors

The addition of plinabulin to non-small cell lung cancer (NSCLC) treatment with docetaxel may reduce the frequency of adverse events and help prevent dose reductions due to toxicity, according to an abstract at the...

The...

06/02/2016

Journal of Clinical Pathways

Research in Review

Review of EGFR Mutation-Positive NSCLC Drugs Identifies Optimal Treatments

06/02/2016

JCP Editors

A review of treatments for non-small cell lung cancer (NSCLC) that is epidermal growth factor receptor mutation positive (EGFR M+) has identified which therapies are the most effective at managing disease symptoms...

A...

06/02/2016

Journal of Clinical Pathways

Transplant Still Preferred Treatment Choice in Young Patients With Myeloma

05/31/2016

JCP Editors

Autologous stem cell transplantation (ASCT) is still the preferred treatment of choice for patients under the age of 65 years with newly diagnosed multiple myeloma (NDMM), according to early results from a phase 3...

...

05/31/2016

Journal of Clinical Pathways

Research in Review

Weight Gain a Sign of Successful Treatment in Patients With NSCLC

05/24/2016

JCP Editors

Weight gain may be an indicator of successful treatment for patients with non-small cell lung cancer (NSCLC), according to findings from a recently published article. Past studies have linked unintentional weigh...

Weight...

05/24/2016

Journal of Clinical Pathways

Research in Review

Evolution of Treatment Strategies for Renal Cancer

05/13/2016

JCP Editors

A look at 14 years of health care trends has revealed that the percentage of patients receiving treatment for metastatic renal cell carcinoma (mRCC) is growing as providers shift toward targeted therapeutic...

A look...

05/13/2016

Journal of Clinical Pathways

Research in Review

Chemoradiotherapy Does Not Improve Survival for Patients With Pancreatic Cancer

05/11/2016

JCP Editors

Adding radiation to chemotherapy regimens may not improve overall survival compared with chemotherapy alone in patients with locally advanced pancreatic cancer, according to results from a clinical trial. The trial,...

Adding...

05/11/2016

Journal of Clinical Pathways

Research in Review

High-Dose Treatment for Acute Lymphoblastic Leukemia Safe, Improves Survival

04/29/2016

JCP Editors

Initial results from a clinical trial have shown that high-dose methotrexate may be superior to standard, low-dose regimens without increasing toxicity for children and young adults with high-risk B-acute...

...

04/29/2016

Journal of Clinical Pathways